(Reuters) -Eli Lilly said on Saturday its experimental pill orforglipron helped diabetics lose weight and lower their blood sugar, and the company aims to announce in the third quarter trial ...

Eli Lilly will acquire gene-editing startup Verve Therapeutics for up to $1.3 billion, the companies said on Tuesday, accelerating a push into experimental cardiovascular therapies.

A new study published in Frontiers in Nutrition warns that people taking popular GLP-1 weight-loss drugs for obesity such as semaglutide (Ozempic) and tirzepatide (Mounjaro) may not be getting enough ...

Eli Lilly and Company (NYSE:LLY – Free Report) – Analysts at Leerink Partnrs decreased their Q1 2025 EPS estimates for shares of Eli Lilly and Company in a report issued on Monday, April 21st ...

The human insulin, Humulin, was approved in a record-setting five months at a time when the average approval time for a New Drug Application was 31.5 months. Biopharmaceuticals now dominate the list ...

Description (Brief) Humulin is human insulin used for treating diabetes. Prior to its development, diabetics used insulin isolated from pig and cow pancreases. Developed by Genentech, the first ...

HAYA, Lilly Launch Up-to-$1B Metabolic Collaboration Pharma giant plans to apply Swiss biotech’s RNA-guided regulatory genome platform to support preclinical drug discovery efforts in obesity ...

Find out about possible interactions between Humulin R and other medications, supplements, alcohol, foods, and more.

The key to keeping healthy as you age is regularly swinging your arms, latest research demonstrates. Scientists have discovered that doing a traditional Chinese arm-swinging exercise ‘Shuai Shou Gong’ ...

The Danish drugmaker said Tuesday that pre-filled pens and vials of long- and short-acting insulins will see list price reductions. They include Levemir, Novolin, NovoLog and NovoLog Mix70/30.